UNIKERIS LIMITED

12490954
Active Manchester

Wholesale of pharmaceutical goods

0 employees website.com
Wholesale of pharmaceutical goods
U

UNIKERIS LIMITED

12490954

Wholesale of pharmaceutical goods

Founded 2 Mar 2020 Active Manchester, England 0 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 4 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 12 Mar 2026 Next due 15 Mar 2027 9 months remaining
Net assets £554M £20M 2024 year on year
Total assets £566M £20M 2024 year on year
Total Liabilities £12M £197K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

333 Styal Road Manchester M22 5LG England

Email

info@example.com

Website

www.example.com

Full company profile for UNIKERIS LIMITED (12490954), an active company based in Manchester, England. Incorporated 2 Mar 2020. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2020–2024)

Cash in Bank

£4.17M

Increased by £1.99M (+92%)

Net Assets

£553.87M

Decreased by £19.71M (-3%)

Total Liabilities

£12.21M

Decreased by £197.35k (-2%)

Turnover

£115.54M

Increased by £5.88M (+5%)

Employees

N/A

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 299,900 Shares £300k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Dec 2021299,900€300k€300k

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Chiesi Farmaceutici S.p.a.
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Chiesi Farmaceutici S.p.a.

Ceased 5 Jun 2023

Ceased

Leadiant Biosciences Limited

Ceased 26 Mar 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
12 Mar 2026Confirmation StatementConfirmation statement made on 1 Mar 2026 with no updates
10 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
28 Apr 2025OfficersTermination of Matthew Hammond Wiggetts as director on 17 Apr 2025
28 Apr 2025OfficersAppointment of Miss Laura Amy Lovell as director on 17 Apr 2025
4 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

12 Mar 2026 Confirmation Statement

Confirmation statement made on 1 Mar 2026 with no updates

10 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

28 Apr 2025 Officers

Termination of Matthew Hammond Wiggetts as director on 17 Apr 2025

28 Apr 2025 Officers

Appointment of Miss Laura Amy Lovell as director on 17 Apr 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 weeks ago on 4 Jun 2026

Confirmation statement made on 1 Mar 2026 with no updates

3 months ago on 12 Mar 2026

Annual accounts made up to 31 Dec 2024

1 years ago on 10 Jun 2025

Termination of Matthew Hammond Wiggetts as director on 17 Apr 2025

1 years ago on 28 Apr 2025

Appointment of Miss Laura Amy Lovell as director on 17 Apr 2025

1 years ago on 28 Apr 2025